The DOI matches its Crossref record; 490 of the 490 references it cites were found in a registry or an index.
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Open accessAbstract
The tumor microenvironment (TME) is a complex and ever-changing “rogue organ” composed of its own blood supply, lymphatic and nervous systems, stroma, immune cells and extracellular matrix (ECM). These complex components, utilizing both benign and malignant cells, nurture the harsh, immunosuppressive and nutrient-deficient environment necessary for tumor cell growth, proliferation and phenotypic flexibility and variation. An important aspect of the TME is cellular crosstalk and cell-to-ECM communication. This interaction induces the release of soluble factors responsible for immune evasion and ECM remodeling, which further contribute to therapy resistance. Other aspects are the presence of exosomes contributed by both malignant and benign cells, circulating deregulated microRNAs and TME-specific metabolic patterns which further potentiate the progression and/or resistance to therapy. In addition to biochemical signaling, specific TME characteristics such as the hypoxic environment, metabolic derangements, and abnormal mechanical forces have been implicated in the development of treatment resistance. In this review, we will provide an overview of tumor microenvironmental composition, structure, and features that influence immune suppression and contribute to treatment resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 490
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
Kim, N. H., Kim, H. S., Li, X.-Y., Lee, I., Choi, H.-S., Kang, S. E., Cha, S. Y., Ryu, J. K., Yoon, D., Fearon, E. R., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201103097 · Cited by 432
Hedgehog beyond medulloblastoma and basal cell carcinoma
Teglund, S., & Toftgård, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.003 · Cited by 426
Dahl, K. N., Kahn, S. M., Wilson, K. L., & Discher, D. E. (2004) · Journal of Cell Science · doi:10.1242/jcs.01357 · Cited by 424
Epigenetics in cancer stem cells
Toh, T. B., Lim, J. J., & Chow, E. K.-H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0596-9 · Cited by 422
Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
Huang, D., Ding, Y., Zhou, M., Rini, B. I., Petillo, D., Qian, C.-N., Kahnoski, R., Futreal, P. A., Furge, K. A., & Teh, B. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3965 · Cited by 417
Humoral immunity, inflammation and cancer
Tan, T.-T., & Coussens, L. M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.001 · Cited by 417
Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
Li, I., & Nabet, B. Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0975-5 · Cited by 416
Queen, M. M., Ryan, R. E., Holzer, R. G., Keller-Peck, C. R., & Jorcyk, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1734 · Cited by 413
Feeling Stress: The Mechanics of Cancer Progression and Aggression
Northcott, J. M., Dean, I. S., Mouw, J. K., & Weaver, V. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00017 · Cited by 409
Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair
Hocking, A. M., & Gibran, N. S. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.05.009 · Cited by 408
Tsuyada, A., Chow, A., Wu, J., Somlo, G., Chu, P., Loera, S., Luu, T., Li, A. X., Wu, X., Ye, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3567 · Cited by 407
De Wever, O., Nguyen, Q., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., & Mareel, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-1110fje · Cited by 402
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
Chen, W., Dong, J., Haiech, J., Kilhoffer, M.-C., & Zeniou, M. (2016) · Stem Cells International · doi:10.1155/2016/1740936 · Cited by 402
Identification of the cell lineage at the origin of basal cell carcinoma
Youssef, K. K., Van Keymeulen, A., Lapouge, G., Beck, B., Michaux, C., Achouri, Y., Sotiropoulou, P. A., & Blanpain, C. (2010) · Nature Cell Biology · doi:10.1038/ncb2031 · Cited by 401
Inohara, N. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1686 · Cited by 396
Carosella, E. D., Rouas-Freiss, N., Roux, D. T.-L., Moreau, P., & LeMaoult, J. (2015) · Advances in Immunology · doi:10.1016/bs.ai.2015.04.001 · Cited by 395
Myant, K. B., Cammareri, P., McGhee, E. J., Ridgway, R. A., Huels, D. J., Cordero, J. B., Schwitalla, S., Kalna, G., Ogg, E.-L., Athineos, D., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.04.006 · Cited by 391
The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
Scherz-Shouval, R., Santagata, S., Mendillo, M. L., Sholl, L. M., Ben-Aharon, I., Beck, A. H., Dias-Santagata, D., Koeva, M., Stemmer, S. M., Whitesell, L., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.045 · Cited by 386
Nuclear Mechanics and Mechanotransduction in Health and Disease
Isermann, P., & Lammerding, J. (2013) · Current Biology · doi:10.1016/j.cub.2013.11.009 · Cited by 384
Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030563 · Cited by 371
Heusinkveld, M., de Vos van Steenwijk, P. J., Goedemans, R., Ramwadhdoebe, T. H., Gorter, A., Welters, M. J. P., van Hall, T., & van der Burg, S. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100889 · Cited by 368
Autophagy, cancer stem cells and drug resistance
Smith, A. G., & Macleod, K. F. (2019) · The Journal of Pathology · doi:10.1002/path.5222 · Cited by 365
Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics
Gerweck, L. E., Vijayappa, S., & Kozin, S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0024 · Cited by 362
The nuclear envelope environment and its cancer connections
Chow, K.-H., Factor, R. E., & Ullman, K. S. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3219 · Cited by 359
Maddocks, O. D. K., & Vousden, K. H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0735-5 · Cited by 355
Shamamian, P., Schwartz, J. D., Pocock, B. J. Z., Monea, S., Whiting, D., Marcus, S. G., & Mignatti, P. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10014 · Cited by 353
The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
Mbongue, J., Nicholas, D., Torrez, T., Kim, N.-S., Firek, A., & Langridge, W. (2015) · Vaccines · doi:10.3390/vaccines3030703 · Cited by 351
Focus on lymphangiogenesis in tumor metastasis
Achen, M. G., McColl, B. K., & Stacker, S. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.017 · Cited by 351
Zhang, Y., Yang, P., Sun, T., Li, D., Xu, X., Rui, Y., Li, C., Chong, M., Ibrahim, T., Mercatali, L., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2690 · Cited by 350
Hu, Y., Yan, C., Mu, L., Huang, K., Li, X., Tao, D., Wu, Y., & Qin, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125625 · Cited by 348
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Di Tomaso, T., Mazzoleni, S., Wang, E., Sovena, G., Clavenna, D., Franzin, A., Mortini, P., Ferrone, S., Doglioni, C., Marincola, F. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2730 · Cited by 344
The Role of the Extracellular Matrix in Cancer Stemness
Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00086 · Cited by 344
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity
Wainwright, E. N., & Scaffidi, P. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.004 · Cited by 342
Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., Node, M., & Imamura, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00103.x · Cited by 339
Targeting the tumor vasculature to enhance T cell activity
Lanitis, E., Irving, M., & Coukos, G. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.011 · Cited by 338
Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression
Shojaei, F., Singh, M., Thompson, J. D., & Ferrara, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712185105 · Cited by 334
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2743 · Cited by 334
Lau, E. Y. T., Lo, J., Cheng, B. Y. L., Ma, M. K. F., Lee, J. M. F., Ng, J. K. Y., Chai, S., Lin, C. H., Tsang, S. Y., Ma, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.019 · Cited by 334
Lipid metabolism and carcinogenesis, cancer development.
Long, J., Zhang, C., Zhu, N., Du, K., Yin, Y., Tan, X., Liao, D., & Li, Q. (2018) · Europe PMC (PubMed Central) · Cited by 330
Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
Yang, F., Ning, Z., Ma, L., Liu, W., Shao, C., Shu, Y., & Shen, H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0718-4 · Cited by 329
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis
Schioppa, T., Moore, R., Thompson, R. G., Rosser, E. C., Kulbe, H., Nedospasov, S., Mauri, C., Coussens, L. M., & Balkwill, F. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100994108 · Cited by 328
Creating immune privilege: active local suppression that benefits friends, but protects foes
Mellor, A. L., & Munn, D. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2233 · Cited by 327
B7-H1 Is Expressed by Human Endothelial Cells and Suppresses T Cell Cytokine Synthesis
Mazanet, M. M., & Hughes, C. C. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3581 · Cited by 326
Forcing form and function: biomechanical regulation of tumor evolution
Yu, H., Mouw, J. K., & Weaver, V. M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.08.015 · Cited by 321
Mechanotransduction in tumor progression: The dark side of the force
Broders-Bondon, F., Nguyen Ho-Bouldoires, T. H., Fernandez-Sanchez, M.-E., & Farge, E. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201701039 · Cited by 319
Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells
Kusmartsev, S., Nagaraj, S., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4583 · Cited by 310
The functional Interactions Between the MAPK and p53 Signaling Pathways
Wu, G. S. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.614 · Cited by 310
Breast cancer cells rely on environmental pyruvate to shape the metastatic niche
Elia, I., Rossi, M., Stegen, S., Broekaert, D., Doglioni, G., van Gorsel, M., Boon, R., Escalona-Noguero, C., Torrekens, S., Verfaillie, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0977-x · Cited by 309
Riekstina, U., Cakstina, I., Parfejevs, V., Hoogduijn, M., Jankovskis, G., Muiznieks, I., Muceniece, R., & Ancans, J. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9094-9 · Cited by 307
Krambeck, A. E., Thompson, R. H., Dong, H., Lohse, C. M., Park, E. S., Kuntz, S. M., Leibovich, B. C., Blute, M. L., Cheville, J. C., & Kwon, E. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600937103 · Cited by 305
Deryugina, E. I., Zajac, E., Juncker-Jensen, A., Kupriyanova, T. A., Welter, L., & Quigley, J. P. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.013 · Cited by 304
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
Komarova, S., Kawakami, Y., Stoff-Khalili, M. A., Curiel, D. T., & Pereboeva, L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0334 · Cited by 302
Akalay, I., Janji, B., Hasmim, M., Noman, M. Z., André, F., De Cremoux, P., Bertheau, P., Badoual, C., Vielh, P., Larsen, A. K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2432 · Cited by 302
Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance
Iwamoto, H., Abe, M., Yang, Y., Cui, D., Seki, T., Nakamura, M., Hosaka, K., Lim, S., Wu, J., He, X., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.005 · Cited by 300
Apicella, M., Giannoni, E., Fiore, S., Ferrari, K. J., Fernández-Pérez, D., Isella, C., Granchi, C., Minutolo, F., Sottile, A., Comoglio, P. M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.006 · Cited by 299
Metabolism shapes the tumor microenvironment
Reina-Campos, M., Moscat, J., & Diaz-Meco, M. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.05.006 · Cited by 293
Kim-Fuchs, C., Le, C. P., Pimentel, M. A., Shackleford, D., Ferrari, D., Angst, E., Hollande, F., & Sloan, E. K. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.02.019 · Cited by 287
Castells, M., Thibault, B., Delord, J.-P., & Couderc, B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13089545 · Cited by 285
Laoui, D., Keirsse, J., Morias, Y., Van Overmeire, E., Geeraerts, X., Elkrim, Y., Kiss, M., Bolli, E., Lahmar, Q., Sichien, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms13720 · Cited by 277
Rubie, C., Kempf, K., Hans, J., Su, T., Tilton, B., Georg, T., Brittner, B., Ludwig, B., & Schilling, M. (2005) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2004.10.001 · Cited by 275
Obesity and Breast Cancer: Role of Leptin
Sánchez-Jiménez, F., Pérez-Pérez, A., de la Cruz-Merino, L., & Sánchez-Margalet, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00596 · Cited by 268
Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V., & Gillies, R. J. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1644 · Cited by 265
Aerobically Derived Lactate Stimulates Revascularization and Tissue Repair via Redox Mechanisms
Hunt, T. K., Aslam, R. S., Beckert, S., Wagner, S., Ghani, Q. P., Hussain, M. Z., Roy, S., & Sen, C. K. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1674 · Cited by 261
Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
Marchesi, F., Piemonti, L., Mantovani, A., & Allavena, P. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.001 · Cited by 260
Wu, C., Calcagno, A. M., & Ambudkar, S. V. (2008) · Current Molecular Pharmacology · doi:10.2174/1874-470210801020093 · Cited by 259
Takahashi, H., Sakakura, K., Kudo, T., Toyoda, M., Kaira, K., Oyama, T., & Chikamatsu, K. (2017) · Oncotarget · doi:10.18632/oncotarget.14374 · Cited by 259
Skuli, N., Liu, L., Runge, A., Wang, T., Yuan, L., Patel, S., Iruela-Arispe, L., Simon, M. C., & Keith, B. (2009) · Blood · doi:10.1182/blood-2008-12-193581 · Cited by 255
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
Bluemlein, K., Grüning, N.-M., Feichtinger, R. G., Lehrach, H., Kofler, B., & Ralser, M. (2011) · Oncotarget · doi:10.18632/oncotarget.278 · Cited by 253
Noman, M. Z., Janji, B., Abdou, A., Hasmim, M., Terry, S., Tan, T. Z., Mami-Chouaib, F., Thiery, J. P., & Chouaib, S. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1263412 · Cited by 253
Cytotoxic immunological synapses
Dustin, M. L., & Long, E. O. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00904.x · Cited by 251
Understanding the Structure and Function of the Immunological Synapse
Dustin, M. L., Chakraborty, A. K., & Shaw, A. S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002311 · Cited by 248
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
Tracz-Gaszewska, Z., & Dobrzyn, P. (2019) · Cancers · doi:10.3390/cancers11070948 · Cited by 248
Functional Similarities Among Genes Regulated by Oct4 in Human Mesenchymal and Embryonic Stem Cells
Greco, S. J., Liu, K., & Rameshwar, P. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0351 · Cited by 246
Liu, J., Zhang, N., Li, Q., Zhang, W., Ke, F., Leng, Q., Wang, H., Chen, J., & Wang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019495 · Cited by 245
Qiu, G.-Z., Jin, M.-Z., Dai, J.-X., Sun, W., Feng, J.-H., & Jin, W.-L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 245
Zhang, X., Xu, L., & Wang, F. (2017) · Cell Biology International · doi:10.1002/cbin.10826 · Cited by 241
Jiang, X., Tan, J., Li, J., Kivimäe, S., Yang, X., Zhuang, L., Lee, P. L., Chan, M. T. W., Stanton, L. W., Liu, E. T., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.019 · Cited by 235
Daurkin, I., Eruslanov, E., Stoffs, T., Perrin, G. Q., Algood, C., Gilbert, S. M., Rosser, C. J., Su, L.-M., Vieweg, J., & Kusmartsev, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1261 · Cited by 235
The hematopoietic stem cell and its niche: a comparative view
Martinez-Agosto, J. A., Mikkola, H. K. A., Hartenstein, V., & Banerjee, U. (2007) · Genes & Development · doi:10.1101/gad.1602607 · Cited by 225
Cojoc, M., Peitzsch, C., Kurth, I., Trautmann, F., Kunz-Schughart, L. A., Telegeev, G. D., Stakhovsky, E. A., Walker, J. R., Simin, K., Lyle, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1924 · Cited by 223
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Michea, P., Noël, F., Zakine, E., Czerwinska, U., Sirven, P., Abouzid, O., Goudot, C., Scholer-Dahirel, A., Vincent-Salomon, A., Reyal, F., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0145-8 · Cited by 223
Incio, J., Ligibel, J. A., McManus, D. T., Suboj, P., Jung, K., Kawaguchi, K., Pinter, M., Babykutty, S., Chin, S. M., Vardam, T. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0945 · Cited by 222
The role of cancer-derived microRNAs in cancer immune escape
Yi, M., Xu, L., Jiao, Y., Luo, S., Li, A., & Wu, K. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00848-8 · Cited by 221
Tadros, S., Shukla, S. K., King, R. J., Gunda, V., Vernucci, E., Abrego, J., Chaika, N. V., Yu, F., Lazenby, A. J., Berim, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3062 · Cited by 221
Hypoxia Potentiates Glioma-Mediated Immunosuppression
Wei, J., Wu, A., Kong, L.-Y., Wang, Y., Fuller, G., Fokt, I., Melillo, G., Priebe, W., & Heimberger, A. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016195 · Cited by 220
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
Mellor, A. L., Lemos, H., & Huang, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01360 · Cited by 219
Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress
LaMonte, G., Tang, X., Chen, J. L.-Y., Wu, J., Ding, C.-K. C., Keenan, M. M., Sangokoya, C., Kung, H.-N., Ilkayeva, O., Boros, L. G., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-23 · Cited by 218
Sata, M., & Walsh, K. (1998) · Nature Medicine · doi:10.1038/nm0498-415 · Cited by 215
Ghanbari Movahed, Z., Rastegari-Pouyani, M., Mohammadi, M. H., & Mansouri, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108690 · Cited by 208
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body
Pan, C., Schoppe, O., Parra-Damas, A., Cai, R., Todorov, M. I., Gondi, G., von Neubeck, B., Böğürcü-Seidel, N., Seidel, S., Sleiman, K., et al. (2019) · Cell · doi:10.1016/j.cell.2019.11.013 · Cited by 206
Novel Insights into the Roles of Rho Kinase in Cancer
Wei, L., Surma, M., Shi, S., Lambert-Cheatham, N., & Shi, J. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0382-6 · Cited by 205
Tripathi, S. C., Peters, H. L., Taguchi, A., Katayama, H., Wang, H., Momin, A., Jolly, M. K., Celiktas, M., Rodriguez-Canales, J., Liu, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521812113 · Cited by 204
Calreticulin in the immune system: ins and outs
Raghavan, M., Wijeyesakere, S. J., Peters, L. R., & Del Cid, N. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.08.002 · Cited by 203
Chen, H. L., Gabrilovich, D., Tampé, R., Girgis, K. R., Nadaf, S., & Carbone, D. P. (1996) · Nature Genetics · doi:10.1038/ng0696-210 · Cited by 203
Neutrophils as active regulators of the immune system in the tumor microenvironment
Shaul, M. E., & Fridlender, Z. G. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5mr1216-508r · Cited by 203
Melamed, R., Rosenne, E., Shakhar, K., Schwartz, Y., Abudarham, N., & Ben-Eliyahu, S. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2004.07.004 · Cited by 199
Quennet, V., Yaromina, A., Zips, D., Rosner, A., Walenta, S., Baumann, M., & Mueller-Klieser, W. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.08.012 · Cited by 197
Ren, C., Kumar, S., Chanda, D., Chen, J., Mountz, J. D., & Ponnazhagan, S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0084 · Cited by 196
Williams, A. C., Collard, T. J., & Paraskeva, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202660 · Cited by 196
Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
Le Mercier, I., Poujol, D., Sanlaville, A., Sisirak, V., Gobert, M., Durand, I., Dubois, B., Treilleux, I., Marvel, J., Vlach, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3058 · Cited by 195
Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells
Wang, X., Low, X. C., Hou, W., Abdullah, L. N., Toh, T. B., Mohd Abdul Rashid, M., Ho, D., & Chow, E. K.-H. (2014) · ACS Nano · doi:10.1021/nn503491e · Cited by 193
Association of tamoxifen resistance and lipid reprogramming in breast cancer
Hultsch, S., Kankainen, M., Paavolainen, L., Kovanen, R.-M., Ikonen, E., Kangaspeska, S., Pietiäinen, V., & Kallioniemi, O. (2018) · BMC Cancer · doi:10.1186/s12885-018-4757-z · Cited by 193
Ruella, M., Klichinsky, M., Kenderian, S. S., Shestova, O., Ziober, A., Kraft, D. O., Feldman, M., Wasik, M. A., June, C. H., & Gill, S. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0850 · Cited by 191
Wagner, W., Ciszewski, W. M., & Kania, K. D. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0114-x · Cited by 190
Nakashima, R. A., Paggi, M. G., & Pedersen, P. L. (1984) · PubMed · Cited by 189
Costa, N. L., Valadares, M. C., Souza, P. P. C., Mendonça, E. F., Oliveira, J. C., Silva, T. A., & Batista, A. C. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2012.09.012 · Cited by 188
Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer
Yeo, E.-J., Cassetta, L., Qian, B.-Z., Lewkowich, I., Li, J.-F., Stefater, J. A., Smith, A. N., Wiechmann, L. S., Wang, Y., Pollard, J. W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2421 · Cited by 187
Heinemann, A., Zhao, F., Pechlivanis, S., Eberle, J., Steinle, A., Diederichs, S., Schadendorf, D., & Paschen, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1977 · Cited by 187
Epigenetic alteration and microRNA dysregulation in cancer
Suzuki, H., Maruyama, R., Yamamoto, E., & Kai, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00258 · Cited by 186
Pang, W., Su, J., Wang, Y., Feng, H., Dai, X., Yuan, Y., Chen, X., & Yao, W. (2015) · Cancer Science · doi:10.1111/cas.12747 · Cited by 183
Beury, D. W., Parker, K. H., Nyandjo, M., Sinha, P., Carter, K. A., & Ostrand-Rosenberg, S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0414-210r · Cited by 183
Denais, C., & Lammerding, J. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4899-8032-8_20 · Cited by 182
Nagl, L., Horvath, L., Pircher, A., & Wolf, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00766 · Cited by 180
Anikeeva, N., Somersalo, K., Sims, T. N., Thomas, V. K., Dustin, M. L., & Sykulev, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502467102 · Cited by 179
Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-
Ostroukhova, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26490 · Cited by 179
Wilson, E. B., El-Jawhari, J. J., Neilson, A. L., Hall, G. D., Melcher, A. A., Meade, J. L., & Cook, G. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022842 · Cited by 174
Shetty, S., Weston, C. J., Oo, Y. H., Westerlund, N., Stamataki, Z., Youster, J., Hubscher, S. G., Salmi, M., Jalkanen, S., Lalor, P. F., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002961 · Cited by 173
CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer
Han, S., Wei, R., Zhang, X., Jiang, N., Fan, M., Huang, J. H., Xie, B., Zhang, L., Miao, W., Butler, A. C.-P., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01201 · Cited by 172
Riesenberg, R., Weiler, C., Spring, O., Eder, M., Buchner, A., Popp, T., Castro, M., Kammerer, R., Takikawa, O., Hatz, R. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0942 · Cited by 170
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
Eichmüller, S. B., Osen, W., Mandelboim, O., & Seliger, B. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx034 · Cited by 170
Anastasiadou, E., Stroopinsky, D., Alimperti, S., Jiao, A. L., Pyzer, A. R., Cippitelli, C., Pepe, G., Severa, M., Rosenblatt, J., Etna, M. P., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0178-x · Cited by 168
Gavalas, N. G., Tsiatas, M., Tsitsilonis, O., Politi, E., Ioannou, K., Ziogas, A. C., Rodolakis, A., Vlahos, G., Thomakos, N., Haidopoulos, D., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.468 · Cited by 167
Palena, C., Polev, D. E., Tsang, K. Y., Fernando, R. I., Litzinger, M., Krukovskaya, L. L., Baranova, A. V., Kozlov, A. P., & Schlom, J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2353 · Cited by 166
Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Dauer, P., Nomura, A., Saluja, A., & Banerjee, S. (2016) · Pancreatology · doi:10.1016/j.pan.2016.12.010 · Cited by 165
Autophagy—A double‐edged sword in oncology
Apel, A., Zentgraf, H., Büchler, M. W., & Herr, I. (2009) · International Journal of Cancer · doi:10.1002/ijc.24500 · Cited by 164
Participation of blood vessel cells in human adaptive immune responses
Pober, J. S., & Tellides, G. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.09.006 · Cited by 164
Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.12.002 · Cited by 164
Kuo, M. T. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2095 · Cited by 163
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
Gao, L., Guo, Q., Li, X., Yang, X., Ni, H., Wang, T., Zhao, Q., Liu, H., Xing, Y., Xi, T., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.034 · Cited by 163
Santoni, M., Massari, F., Amantini, C., Nabissi, M., Maines, F., Burattini, L., Berardi, R., Santoni, G., Montironi, R., Tortora, G., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1487-6 · Cited by 161
Bharadwaj, U., Li, M., Zhang, R., Chen, C., & Yao, Q. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3963 · Cited by 160
Lu, W., Hu, Y., Chen, G., Chen, Z., Zhang, H., Wang, F., Feng, L., Pelicano, H., Wang, H., Keating, M. J., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001326 · Cited by 160
Divergent mutational processes distinguish hypoxic and normoxic tumours
Bhandari, V., Li, C. H., Bristow, R. G., Boutros, P. C., Aaltonen, L. A., Abascal, F., Abeshouse, A. A., Aburatani, H., Adams, D. J., Agrawal, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14052-x · Cited by 160
Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells
Hussain, M., Rao, M., Humphries, A. E., Hong, J. A., Liu, F., Yang, M., Caragacianu, D., & Schrump, D. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2807 · Cited by 159
Michaeli, J., Shaul, M. E., Mishalian, I., Hovav, A.-H., Levy, L., Zolotriov, L., Granot, Z., & Fridlender, Z. G. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1356965 · Cited by 159
Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Li, H., Feng, Z., & He, M.-L. (2020) · Theranostics · doi:10.7150/thno.41388 · Cited by 159
Immunosuppressive properties of cloned bone marrow mesenchymal stem cells
Xu, G., Zhang, L., Ren, G., Yuan, Z., Zhang, Y., Zhao, R. C. H., & Shi, Y. (2007) · Cell Research · doi:10.1038/cr.2007.4 · Cited by 158
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation
Shen, S., Faouzi, S., Souquere, S., Roy, S., Routier, E., Libenciuc, C., André, F., Pierron, G., Scoazec, J.-Y., & Robert, C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108421 · Cited by 158
Yan, X., Fu, C., Chen, L., Qin, J., Zeng, Q., Yuan, H., Nan, X., Chen, H., Zhou, J., Lin, Y.-L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1577-0 · Cited by 157
Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes
Wong, B. W., Kuchnio, A., Brüning, U., & Carmeliet, P. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.10.004 · Cited by 157
Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan
Vukovic, V., & Tannock, I. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.201 · Cited by 156
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
Kadera, B. E., Li, L., Toste, P. A., Wu, N., Adams, C. E., Dawson, D. W., & Donahue, T. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071978 · Cited by 155
Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?
Morgan, R., Mortensson, E., & Williams, A. C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0118-6 · Cited by 153
Targeting immune suppressing myeloid-derived suppressor cells in oncology
Kao, J., Ko, E. C., Eisenstein, S. G., Sikora, A. G., Fu, S., & Chen, S. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.02.004 · Cited by 151
Joyce, M. H., Lu, C., James, E. R., Hegab, R. A., Allen, S. C., Suggs, L. J., & Brock, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00337 · Cited by 151
Hernández, R. E. H., Jiménez‐Luna, C., Perales-Adán, J., Perazzoli, G., Melguizo, C., & Prados, J. C. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.065 · Cited by 150
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?
Vara‐Ciruelos, D., Russell, F. M., & Hardie, D. G. (2019) · Open Biology · doi:10.1098/rsob.190099 · Cited by 149
Fidler, I. J., & Talmadge, J. E. (1986) · PubMed · Cited by 145
Bollyky, P. L., Wu, R. P., Falk, B. A., Lord, J. D., Long, S. A., Preisinger, A., Teng, B. J., Holt, G. E., Standifer, N. E., Braun, K. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017360108 · Cited by 145
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Lin, A., & Yan, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02164 · Cited by 145
Epigenetic gene silencing in the Wnt pathway in breast cancer
Klarmann, G. J., Decker, A., & Farrar, W. L. (2008) · Epigenetics · doi:10.4161/epi.3.2.5899 · Cited by 144
Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening
Nguyen, T. V., Sleiman, M., Moriarty, T., Herrick, W. G., & Peyton, S. R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.058 · Cited by 143
The dark side of tumor-associated endothelial cells
Sanctis, F. D., Ugel, S., Facciponte, J. G., & Facciabene, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.002 · Cited by 143
miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
Xi, J., Huang, Q., Wang, L., Ma, X., Deng, Q., Kumar, M., Zhou, Z., Li, L., Zeng, Z., Young, K. H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0178-3 · Cited by 143
Lipid Metabolism at the Nexus of Diet and Tumor Microenvironment
Peck, B., & Schulze, A. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.09.007 · Cited by 143
The expression and role of CXC chemokines in colorectal cancer
Verbeke, H., Struyf, S., Laureys, G., & Damme, J. V. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.002 · Cited by 139
Gao, F., Zhao, Z., Zhao, W., Fan, Q.-R., Wang, S., Li, J., Zhang, Y., Shi, J., Lin, X., Yang, S., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.097 · Cited by 138
PD-L1 is an activation-independent marker of brown adipocytes
Ingram, J. R., Dougan, M. L., Rashidian, M., Knoll, M., Keliher, E. J., Garrett, S., Garforth, S., Blomberg, O. S., Espinosa, C. A., Bhan, A. K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00799-8 · Cited by 138
Epigenetics of cancer stem cells: Pathways and therapeutics
Shukla, S., & Meeran, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.09.017 · Cited by 135
Wang, Y., Guo, R., Guo, R., Wei, S., & Yin, L. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24488 · Cited by 134
Liu, Y., Lv, J., Liang, X., Yin, X., Zhang, L., Chen, D., Jin, X., Fiskesund, R., Tang, K., Ma, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3719 · Cited by 133
Tanaka, K., Miyata, H., Sugimura, K., Fukuda, S., Kanemura, T., Yamashita, K., Miyazaki, Y., Takahashi, T., Kurokawa, Y., Yamasaki, M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv067 · Cited by 132
Action and Traction: Cytoskeletal Control of Receptor Triggering at the Immunological Synapse
Comrie, W. A., & Burkhardt, J. K. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00068 · Cited by 132
Pundavela, J., Demont, Y., Jobling, P., Lincz, L. F., Roselli, S., Thorne, R. F., Bond, D. R., Bradshaw, R. A., Walker, M. M., & Hondermarck, H. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.009 · Cited by 129
Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells
You, Y., Zheng, Q., Dong, Y., Xie, X., Wang, Y., Wu, S., Zhang, L., Wang, Y., Xue, T., Wang, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8515 · Cited by 128
Senescent stroma promotes prostate cancer progression: The role of miR‐210
Taddei, M. L., Cavallini, L., Comito, G., Giannoni, E., Folini, M., Marini, A., Gandellini, P., Morandi, A., Pintus, G., Raspollini, M. R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.009 · Cited by 127
Jolly, M. K., Kulkarni, P., Weninger, K., Orban, J. P., & Levine, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00050 · Cited by 126
CCL18 in the Progression of Cancer
Korbecki, J., Olbromski, M., & Dzięgiel, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217955 · Cited by 126
Yang, J., Li, B., Lu, H.-W., Chen, Y., Lu, C., Zhu, R.-X., Liu, S.-H., Yi, Q., Li, J., & Song, C.-H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2938-1 · Cited by 125
Periostin Is Expressed in Pericryptal Fibroblasts and Cancer-associated Fibroblasts in the Colon
Kikuchi, Y., Kashima, T. G., Nishiyama, T., Shimazu, K., Morishita, Y., Shimazaki, M., Kii, I., Horie, H., Nagai, H., Kudō, A., et al. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.951061 · Cited by 125
To, K. K. W., Polgár, O., Huff, L. M., Morisaki, K., & Bates, S. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0175 · Cited by 125
Wang, J., Guan, X., Zhang, Y., Ge, S., Zhang, L., Li, H., Wang, X., Liu, R., Ning, T., Deng, T., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493218 · Cited by 125
Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells
Bhatt, A. N., Chauhan, A., Khanna, S., Rai, Y., Singh, S. P., Soni, R., Kalra, N., & Dwarakanath, B. S. R. (2015) · BMC Cancer · doi:10.1186/s12885-015-1368-9 · Cited by 124
The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy
Chen, J.-C., Chang, Y.-W., Hong, C., Yu, Y. H., & Su, J. L. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010088 · Cited by 124
Bessa, C., Soares, J., Raimundo, L., Loureiro, J. B., Gomes, C. M. F., Reis, F., Soares, M. L., dos Santos, D. J. V. A., Dureja, C., Chaudhuri, S. R., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0154-9 · Cited by 123
Fujimura, T., Kambayashi, Y., & Aiba, S. (2012) · OncoImmunology · doi:10.4161/onci.21176 · Cited by 122
Matsushita, H., Hosoi, A., Ueha, S., Abe, J., Fujieda, N., Tomura, M., Maekawa, R., Matsushima, K., Ohara, O., & Kakimi, K. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0098 · Cited by 121
Ashizawa, M., Okayama, H., Ishigame, T., Min, A. K. T., Saito, K., Ujiie, D., Murakami, Y., Kikuchi, T., Nakayama, Y., Noda, M., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0831 · Cited by 121
Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells
Saunders, D. E., Lawrence, W. D., CHRISTENSEN, C. W., Wappler, N. L., Ruan, H., & Deppe, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970117)70:2<214::aid-ijc13>3.0.co;2-i · Cited by 120
Cho, S., Lü, M., He, X., Ee, P. L. R., Bhat, U. G., Schneider, E., Miele, L., & Beck, W. T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019452108 · Cited by 120
Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
Stahl, M., Schupp, J. C., Jäger, B., Schmid, M., Zissel, G., Müller–Quernheim, J., & Prasse, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081382 · Cited by 118
Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions
Taflin, C., Favier, B., Baudhuin, J., Savenay, A., Hémon, P., Bensussan, A., Charron, D. J., Glotz, D., & Mooney, N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011811108 · Cited by 118
CD68+HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway
Wang, H., Wang, X., Li, X., Fan, Y., Li, G., Guo, C., Zhu, F., Zhang, L., & Shi, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.013 · Cited by 117
Ristorcelli, E., Béraud, E., Mathieu, S., Lombardo, D., & Vérine, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24375 · Cited by 116
Zhang, H., Zhang, X., Wu, X., Li, W., Su, P., Cheng, H., Xiang, L., Gao, P., & Zhou, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.039 · Cited by 116
Jinushi, M., & Komohara, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.01.002 · Cited by 115
Fritah, A., Saucier, C., Wever, O. D., Bracke, M., Bièche, I., Lidereau, R., Gespach, C. P., Drouot, S., Redeuilh, G., & Sabbah, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01335-07 · Cited by 114
The Extracellular, Cellular, and Nuclear Stiffness, a Trinity in the Cancer Resistome—A Review
Deville, S. S., & Cordes, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01376 · Cited by 113
Wnt Signaling, Stem Cells, and the Cellular Origin of Breast Cancer
Lindvall, C. J., Bu, W., Williams, B. O., & Li, Y. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0025-3 · Cited by 112
Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
Jahanban-Esfahlan, R., Seidi, K., Manjili, M. H., Jahanban-Esfahlan, A., Javaheri, T., & Zare, P. (2019) · Cancers · doi:10.3390/cancers11081207 · Cited by 111
Egfl7 Promotes Tumor Escape from Immunity by Repressing Endothelial Cell Activation
Delfortrie, S., Pinte, S., Mattot, V., Samson, C., Villain, G., Caëtano, B., Lauridant, G., Baranzelli, M., Bonneterre, J. M., Trottein, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1301 · Cited by 110
The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases
Milner, J. D., & Holland, S. M. (2013) · Nature reviews. Immunology · doi:10.1038/nri3493 · Cited by 108
The role of cancer stem cells in the modulation of anti-tumor immune responses
Maccalli, C., Rasul, K. I., Elawad, M., & Ferrone, S. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.006 · Cited by 108
Targeting acidity in cancer and diabetes
Gillies, R. J., Pilot, C., Marunaka, Y., & Fais, S. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.003 · Cited by 108
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability
Koinuma, K., Yamashita, Y., Liu, W., Hatanaka, H., Kurashina, K., Wada, T., Takada, S., Kaneda, R., Choi, Y. L., Fujiwara, S.-I., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209009 · Cited by 106
Modulation of T cell signaling by the actin cytoskeleton
Yu, Y., Smoligovets, A. A., & Groves, J. T. (2013) · Journal of Cell Science · doi:10.1242/jcs.098210 · Cited by 104
Energy Metabolism in a Matched Model of Radiation Resistance for Head and Neck Squamous Cell Cancer
Mims, J., Bansal, N., Bharadwaj, M. S., Chen, X., Molina, A. J. A., Tsang, A. W., & Furdui, C. M. (2015) · Radiation Research · doi:10.1667/rr13828.1 · Cited by 104
Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells
Chow, E. K., Fan, L., Chen, X., & Bishop, M. J. (2012) · Hepatology · doi:10.1002/hep.25776 · Cited by 103
Rhodes, L. V., Antoon, J. W., Muir, S. E., Elliott, S. G., Beckman, B. S., & Burow, M. E. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-295 · Cited by 103
Hide-and-seek: the interplay between cancer stem cells and the immune system
Sultan, M., Coyle, K. M., Vidovic, D., Thomas, M. L., Gujar, S. A., & Marcato, P. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw115 · Cited by 103
Cited by
(2023) · doi:10.1038/s41392-022-01304-4 · Cited by 460
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Neophytou, C. M., Trougakos, I. P., Erin, N., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13174363 · Cited by 371
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024) · Cancers · doi:10.3390/cancers16132478 · Cited by 339
“Dysregulated signaling pathways such as PI3K/Akt/mTOR, MAPK/ERK, and Wnt/ β -catenin contribute to drug resistance and are targets for therapeutic interventions [101].”
Background
Metadata
- Authors
- Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-05-27
- Volume
- 12
- Pages
- 656364-656364
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3170943164
- Cited by
- 513
- References
- 490
- FWCI
- 24.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.